Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIT (Details Narrative 1)

STOCKHOLDERS' DEFICIT (Details Narrative 1)						3 Months Ended		9 Months Ended	12 Months Ended
STOCKHOLDERS' DEFICIT (Details Narrative 1)	Jan. 08, 2015 $ / shares shares	Jul. 31, 2014 $ / shares shares	Mar. 22, 2014 USD ($) Number $ / shares shares	Nov. 08, 2013 $ / shares shares	Oct. 08, 2013	Jun. 30, 2015 $ / shares shares	Mar. 31, 2015 $ / shares shares	Jun. 30, 2015 $ / shares shares	Sep. 30, 2014 $ / shares shares	Dec. 31, 2014 $ / shares shares	Aug. 01, 2014 $ / shares shares	Jun. 20, 2014 $ / shares shares	Mar. 26, 2013 shares	Dec. 10, 2012 shares	Mar. 22, 2012 shares	Aug. 03, 2006 shares
Number of options exercised
Number of options outstanding						12,618,891	12,667,499	12,618,891		12,417,499
Common stock exercise price (in dollars per share) \| $ / shares						$ 0.83	$ 0.83	$ 0.83		$ 0.84
Number of stock options granted							250,000
Warrant [Member]
Number of equity instruments other than options outstanding						781,524	781,524	781,524	814,744	788,724
Number of warrant issued during the period						781,524		781,524				608,309
Exercise price (in dollars per share) \| $ / shares												$ 0.04718
Description of warrant expiration term								The warrants expire at various times starting 2015 through 2019.
Weighted exercise price (in dollars per share) \| $ / shares								$ 0.53
Warrant [Member] \| Monarch Capital [Member] \| Private Placement [Member]
Number of accredited investors \| Number			11
Number of warrant issued during the period			120,000
Exercise price (in dollars per share) \| $ / shares			$ 0.275
Value of shares issued during the period \| $			$ 300,000
Warrant [Member] \| D&D Securities [Member] \| Private Placement [Member]
Number of warrant issued during the period			32,200
Exercise price (in dollars per share) \| $ / shares			$ 0.25
Value of shares issued during the period \| $			$ 115,000
Warrant [Member] \| Red Chip Companies, Inc [Member]
Number of warrant issued during the period											200,000
Exercise price (in dollars per share) \| $ / shares											$ 0.25
Warrant [Member] \| Minimum [Member]
Exercise price (in dollars per share) \| $ / shares						$ 0.04718		0.04718
Warrant [Member] \| Maximum [Member]
Exercise price (in dollars per share) \| $ / shares						$ 9.00		$ 9.00
CNS California 2006 Stock Incentive Plan [Member]
Number of shares reserved for future issuance																667,667
Number of options exercised									70,825
Number of options outstanding									501,924
Number of shares expired									87,786
CNS California 2006 Stock Incentive Plan [Member] \| Minimum [Member]
Common stock exercise price (in dollars per share) \| $ / shares									$ 3.60
CNS California 2006 Stock Incentive Plan [Member] \| Maximum [Member]
Common stock exercise price (in dollars per share) \| $ / shares									$ 32.70
CNS California 2006 Stock Incentive Plan [Member] \| Restricted Stock [Member]
Number of equity instruments other than options outstanding									6,132
2012 Omnibus Incentive Compensation Plan [Member]
Number of shares reserved for future issuance						2,883,033		2,883,033
Common stock exercise price (in dollars per share) \| $ / shares	$ 0.25	$ 0.26		$ 0.25
Number of options authorized													15,000,000	5,500,000	333,334
Number of stock options granted	250,000	425,000		700,000				12,116,967
Description of vesting rights	Option vesting is contingent upon the achievement of agreed upon goals.	Options vest evenly over 36 months starting on the date of grant.		Options vest evenly over 48 months starting on the date of grant; consultant options vest evenly over 36 months starting on the date of grant.	These options vested pro-rata over 12 months starting from the date of grant.